Light activated chemotherapy platform for the treatment of early-stage mouth cancers
Biologic quantification provided at the benchtop using electrochemical detection
Bioprocess for scaling patient derived organoids for use in high throughput screening
Leveraging proprietary GRIT platform technology to engineer Tregs to overcome challenges associated with previous generations of Treg cell therapies
Extracellular vesicle platform developing novel therapeutics to regenerate tissue in autoimmune diseases such as rheumatoid arthritis
first-in-class therapeutic targeting novel circulating factor.
first-in-class therapeutics utilising cell depletion approaches for autoimmune and immune mediated inflammatory disorders
first-in-class therapeutic targeting novel metabolite transport